MA (EU) number
(Invented) 
name
Strength
Pharmaceutical 
Form
Route of 
Administration
Immediate 
Packaging
Content 
(concentration)
Pack size
EU/1/12/767/001
Nimenrix  
--¹
EU/1/12/767/002
Nimenrix  
--¹
EU/1/12/767/003
Nimenrix  
--¹
EU/1/12/767/004
Nimenrix  
--¹
EU/1/12/767/008
Nimenrix
--¹
Powder and solvent 
for solution for 
injection
Powder and solvent 
for solution for 
injection
Powder and solvent 
for solution for 
injection
Powder and solvent 
for solution for 
injection
Powder and solvent 
for solution for 
injection
Intramuscular use
Intramuscular use
Intramuscular use
Intramuscular use
Intramuscular use
powder: vial 
(glass); solvent: 
pre-filled syringe 
(glass)
powder: vial 
(glass); solvent: 
pre-filled syringe 
(glass)
powder: vial 
(glass); solvent: 
pre-filled syringe 
(glass)
powder: vial 
(glass); solvent: 
pre-filled syringe 
(glass)
powder: vial 
(glass); solvent: 
vial (glass)
solution: 0.5 ml
1 vial + 1 pre-filled 
syringe 
solution: 0.5 ml
10 vials + 10 
pre-filled syringes 
solution: 0.5 ml
1 vial + 1 pre-filled 
syringe + 2 needles 
solution: 0.5 ml
10 vials + 10 
pre-filled syringe + 
20 needles 
solution: 0.5 ml
50 vials + 50 vials
--¹ Neisseria meningitidis serogroup A polysaccharide* 5 micrograms
Neisseria meningitidis serogroup C polysaccharide* 5 micrograms
Neisseria meningitidis serogroup W-135 polysaccharide* 5 micrograms
Neisseria meningitidis serogroup Y polysaccharide* 5 micrograms
*conjugated to tetanus toxoid carrier protein 44 micrograms
1/1
